Retrospective, Landmark Analysis of Long-term Adult Morbidity Following Allogeneic HSCT for Inborn Errors of Immunity in Infancy and Childhood

PURPOSE: Allogeneic hematopoietic stem cell transplant (HSCT) remains the treatment of choice for patients with inborn errors of immunity (IEI). There is little published medical outcome data assessing late medical complications following transition to adult care. We sought to document event-free su...

Descripción completa

Detalles Bibliográficos
Autores principales: Day, James W., Elfeky, Reem, Nicholson, Bethany, Goodman, Rupert, Pearce, Rachel, Fox, Thomas A., Worth, Austen, Booth, Claire, Veys, Paul, Carpenter, Ben, Hough, Rachael, Gaspar, H. Bobby, Titman, Penny, Ridout, Deborah, Workman, Sarita, Hernandes, Fernando, Sandford, Kit, Laurence, Arian, Campbell, Mari, Burns, Siobhan O., Morris, Emma C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537214/
https://www.ncbi.nlm.nih.gov/pubmed/35579633
http://dx.doi.org/10.1007/s10875-022-01278-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537214/
https://www.ncbi.nlm.nih.gov/pubmed/35579633
http://dx.doi.org/10.1007/s10875-022-01278-6

Ejemplares similares